Related Experiment Video
Updated: Jul 17, 2026
08:29
Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans
Published on: December 18, 2016
Review of dementia
Micheline Dugu1, Judith Neugroschl, Margaret Sewell
1Department of Psychiatry, Box 1230, Mount Sinai School of Medicine, One East 100th Street, New York, NY 10029, USA.
The Mount Sinai Journal of Medicine, New York
|January 8, 2003
Summary
This review covers dementia diagnosis, common causes like Alzheimer's disease, and caregiver challenges. It emphasizes understanding dementia etiology and pathophysiology for better patient and caregiver support.
Area of Science:
- Gerontology
- Neurology
- Public Health
Background:
- Elderly individuals face a heightened risk of dementia, escalating with age.
- Understanding dementia is crucial for effective clinical practice and patient care.
- Key areas include diagnosis, etiology, contributing medical conditions, and pathophysiology.
Purpose of the Study:
- To provide clinicians with a comprehensive overview of dementia.
- To highlight the critical role of caregivers and their management challenges.
- To underscore the necessity of long-term planning for dementia patients and their families.
Main Methods:
- Literature review focusing on dementia diagnosis and etiology.
- Exploration of Alzheimer's disease pathophysiology and related medical conditions.
- Analysis of caregiver burden and management strategies.
Main Results:
- Dementia diagnosis requires understanding various etiological factors.
- Alzheimer's disease, vascular dementia, and Lewy body dementia are common forms.
- Caregiver support and long-term planning are essential components of dementia management.
Conclusions:
- Clinicians must be knowledgeable about dementia's diverse aspects.
- Addressing caregiver needs is paramount for comprehensive dementia care.
- Proactive long-term planning improves outcomes for patients and families.
Related Concept Videos
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:30Dementia
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
The progression of dementia is generally gradual.
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...